Navigation Links
Stent Effective In Keeping Arteries Open

A new type of stent that releases medication appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, // a process known as restenosis. The experimental stent, a mesh tube, releases the immunosuppressant drug everolimus. The drug acts by inhibiting cell reproduction and reducing cell growth in vessel walls. Unlike other similar drug-eluting stents, the one used in this study is made with a biodegradable polymer researchers believe will reduce and minimize long-term inflammation and restenosis.

This unique everolimus-coated stent freezes the biological process that leads to the renarrowing of arteries after catheter-based treatments. Not only are the patients free from symptoms, but they have open arteries 12 months after stent implantation. Results of the study show patients who received the everolimus-coated stents had 87-percent less narrowing in the treated portion of their arteries than those who received uncoated, or bare-metal, stents.

Of the 42 patients in the study, 27 received the new stents and 15 received standard stents. Standard stents have metal mesh tubes used to keep vessels open after balloon angioplasty opens the clogged artery. Everolimus also has promise in preventing heart and kidney rejection after transplantation.
'"/>




Page: 1

Related medicine news :

1. Stent shows promise in keeping arteries open
2. Failure of Drug-Coated Stent
3. Drug-Coated Stent
4. Stronger Backing for Drug-Coated Stents
5. Drug-Coated Stents – Proven to be More Effectiv
6. The Efficacy Of Newer Stents Questioned
7. Analyzing The Side Effects Of Sirolimus Stents
8. Stents That Release Medication To Check Artery Narrowing
9. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
10. Stenting: A Possible Remedy For Brain Artery Blockage
11. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... York (PRWEB) , ... August ... ... LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics provider ... has entered into a definitive agreement to purchase Unitrans International Corporation, a ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, Eppendorf ... they will present the line of epMotion automated liquid handling system. This automated ... automate everyday pipetting tasks. , Ideal for scientists and lab technicians with no ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a ... throughout the greater DC region, is inaugurating a “New Leash On Life” charity ... and training them to be companions for veterans in need. , The Semper ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a ... in east Texas, is launching a regional charity effort to provide publicity assistance ... the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... 30, 2017.  The Company reported second quarter net sales ... prior year period, and an increase of 2.1% on ... of contribution from the LDR Holding Corporation acquisition, second ... of 2016, or 0.3% on a constant currency basis. ...
(Date:7/26/2017)... LOVELAND, Colo. , July 26, 2017 ... Tristan Guttridge and the Bimini SharkLab to custom design the ... diagnostic images of sharks in their native habitat. In ... for Discovery Channel,s Shark Week, Dr. Guttridge approached ... to take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... BEACH, Fla. , July 26, 2017 ... of enrollment of our clinical trial evaluating Altemia TM ... Cell Anemia (SCA) and Sickle Cell Disease (SCD). The ... to evaluate the efficacy and safety of Altemia TM ... trial is conducted under US IND 125274. ...
Breaking Medicine Technology: